Salomon & Ludwin’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$957K Hold
10,318
0.08% 92
2026
Q1
$878K Hold
10,318
0.08% 93
2025
Q4
$794K Buy
10,318
+225
+2% +$17.6K 0.07% 97
2025
Q3
$787K Buy
10,093
+330
+3% +$28.1K 0.07% 94
2025
Q2
$902K Buy
9,763
+8,725
+841% +$797K 0.09% 83
2025
Q1
$97.3K Hold
1,038
0.01% 180
2024
Q4
$94.4K Hold
1,038
0.01% 180
2024
Q3
$108K Hold
1,038
0.01% 182
2024
Q2
$101K Sell
1,038
-78
-7% -$7.2K 0.01% 188
2024
Q1
$100K Buy
1,116
+66
+6% +$5.59K 0.01% 254
2023
Q4
$74.7K Hold
1,050
0.01% 262
2023
Q3
$74.7K Buy
+1,050
New +$78.5K 0.01% 262
2020
Q2
Sell
-800
Closed -$53K 98
2020
Q1
$53K Hold
800
0.01% 90
2019
Q4
$55K Hold
800
0.01% 107
2019
Q3
$59K Hold
800
0.01% 87
2019
Q2
$57K Hold
800
0.01% 89
2019
Q1
$55K Hold
800
0.01% 85
2018
Q4
$48K Buy
+800
New +$50.1K 0.01% 84

Other funds holding CL

Salomon & Ludwin's CL Position: Q2 2026 in Review

Salomon & Ludwin held its Colgate-Palmolive (CL) position steady in Q2 2026 at 10,318 shares worth $957K. The position accounts for 0.08% of the portfolio, ranked #92.

Salomon & Ludwin first reported a position in CL in Q4 2018 and has held it in 18 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Salomon & Ludwin held 10,318 shares of Colgate-Palmolive worth $957K as of Q2 2026.
  • Salomon & Ludwin left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.08% of Salomon & Ludwin's portfolio in Q2 2026, its #92 holding.
  • Salomon & Ludwin first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 18 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.